… patients, unconfirmed complete or partial response in 6% and only 13.3% had a complete
haematological response (83). While, the combination with Dasatinib … they can be successfully …

… the availability of a successful treatment, patients may struggle with … Dasatinib, nilotinib,
bosutinib and ponatinib are now … • Chronic myeloid leukaemia or Chronic myeloid leukemia or …

… delivered dose intensity divided by the standard dose intensity (dasatinib 100mg daily)
multiplied by 100% during … discontinuation of TKIs might improve the success of TFR. However, …

… to poor clinical outcomes in chronic myeloid leukemia (CML). … that behavioural change
techniques delivered by a nurse [17] … Since the success of TKI treatment depends on CML patients…

… leukemia (AML) and chronic myeloid leukemia, (CML).[1] … , instead of dasatinib (as per
the E-WALL protocol) for our patient.[… patients who received full dose chemotherapy post-delivery …

… Nevertheless, side effects of Dasatinib (DA) and PD-L1 drugs during pregnancy, … chronic
myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia […

… Two patients received dasatinib upfront while one patient received … The female patient in
whom TKI was discontinued for pregnancy, had an uncomplicated delivery of a healthy baby …

… with successful Imatinib discontinuation in chronic myeloid … The pregnant lady was also
restarted on Imatinib after delivery of … Dasatinib tyrosine kinase inhibitor as second and third line …

… with MPN appear to have successful pregnancies [11]. … Dasatinib should not be used at any
time during pregnancy. … nilotinib in patients with chronic myeloid leukemia in chronic phase: …

… for providing dasatinib or nilotinib to pediatric patients lacking insurance … DMR is successful
in only limited numbers of patients as … On the other hand, TKI exposure during pregnancy is …